Clinical trial
Prospective, Randomized, Controlled Trial of Preoperative Use of Saxenda (Liraglutide) Additionally to Common Dietological Measures as Opposed to Dietological Measures Alone
NCT06865365 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Randomized, Controlled Trial of Preoperative Use of Saxenda (Liraglutide) Additionally to Common Dietological Measures as Opposed to Dietological Measures Alone
- Lead sponsor
- Medical University of Vienna
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- May 1, 2025
- Completion date
- February 1, 2028
- Enrollment
- 72 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
obesity, adolescent